ARQT Exercise Disclosure
Curran Terrie · SEC Form 4 · Filed Aug 24, 2026
Exercise
Calculated transaction value
$0
Curran Terrie Director
ARQT
Transaction date
Aug 20, 2026
Public filing date
Aug 24, 2026
Filing lag
Filed 4 days later
ARQT daily price context
Close on/before transaction
$25.35
Aug 20, 2026
Close before public filing
$25.08
Aug 21, 2026
Return since public filing
-6.46%
Through Sep 15, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Common Stock
- Quantity / price
- 1,072 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001628280-26-058648
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$35.96K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. ARQT | Exercise | Aug 20, 2026 | $8.05K |
| Arcutis Biotherapeutics, Inc. ARQT | Sale | Aug 20, 2026 | $27.91K |
| Arcutis Biotherapeutics, Inc. ARQT Current | Exercise | Aug 20, 2026 | $0 |